February 12, 2025 03:39 PM EST

NIH’s funding cut plan poses challenges for researchers despite court halt

Nicole DeFeudis

Editor

An NIH cap on indirect cost payments for grant recipients is casting a shroud of uncertainty for research universities despite a judge’s order to block …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

NIH’s funding cut plan poses challenges for researchers despite court halt

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Kaiser Permanente calls on FDA and Congress to firm up accelerated approval requirements

Biogen downplays capacity for M&A; Roche’s SMA drug is approved as a tablet

AbbVie pens another T cell engager deal, this time with Xilio

AnaptysBio gets a mid-stage win for PD-1 drug in rheumatoid arthritis

Novo's weight loss drug helps curb some drinking habits, small study shows

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

NIH’s fund­ing cut plan pos­es chal­lenges for re­searchers de­spite court halt

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

NIH’s funding cut plan poses challenges for researchers despite court halt